Legal Representation
Attorney
Vanessa A. Ignacio, Esq.
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description |
|---|---|---|---|
| Apr 19, 2023 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Sep 19, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Sep 19, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Jun 23, 2022 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Feb 15, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jan 26, 2022 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Dec 21, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Dec 21, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Dec 1, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Nov 9, 2021 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Oct 28, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Oct 28, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Oct 28, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Oct 28, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Oct 28, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Oct 27, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 27, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Oct 27, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Oct 27, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jun 29, 2021 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Jun 28, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 26, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 040
Custom manufacture of medical goods, namely, drug delivery devices in the nature of implanted or topically applied aggregations of liposomes providing timed-release of encapsulated pharmaceuticals, made to the order or specification of others, for treatment of a wide variety of diseases
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research and development of new surgical products, diagnostic products and medical treatments for others; scientific research and development services; development and engineering services in the field of surgical, diagnostic and therapeutic products; product development; design of new products for others; Design of medical goods for others, namely, drug delivery devices in the nature of implanted or topically applied aggregations of liposomes providing timed-release of encapsulated pharmaceuticals, made to the order or specification of others, for treatment of a wide variety of diseases
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the word "PACIRA" in with an arch design running from the first "A" to the second "A" and the literal element "CRYOTECH, INC." directly underneath appearing in smaller font.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
PACIRA CRYO TECH, INCORPORATED
Classification
International Classes
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"CRYOTECH, INC."